皮质类固醇使用与喘儿童骨折风险之间的关联:一项全国性队列研究
Hyunmin Ji1,2, Hye-Ji Han2,3, In-Young Choi2
1Department of Health Science and Technology, Seoul National University, Seoul, Korea.
概括
儿童喘和皮质类固醇使用增加了儿童骨折的风险. 对年轻的喘患者来说,密切监测和骨健康管理至关重要.
科学领域:
- 儿科医学 儿科医学 儿科医学
- 肺部病理学 肺部病理学
- 整形外科 整形外科 整形外科
背景情况:
- 儿童喘是一种慢性炎症状况,与骨折风险增加有关.
- 持续性炎症和皮质类固醇治疗是潜在的促成因素.
- 这项研究研究了韩国儿科喘与骨折风险之间的关联.
研究的目的:
- 调查儿科喘与骨折风险之间的关联.
- 评估皮质类固醇暴露对喘儿童骨折风险的影响.
主要方法:
- 分析韩国国家医疗保险服务国家样本队列 (2002-2019) 的数据.
- 倾向性得分匹配用于比较喘和非喘队列.
- 后勤回归模型分析了骨折风险,对共变量和皮质类固醇暴露进行了调整.
主要成果:
- 喘与骨折的更高风险显著相关 (OR:1.22).
- 最近在骨折后90天内吸入皮质类固醇 (ICS) 的使用显示出最高的风险 (调整后OR:2.98).
- 系统性皮质类固醇使用显示了与骨折风险增加的剂量依赖关系.
结论:
- 儿童喘和皮质类固醇治疗都是骨折的重要危险因素.
- 综合性喘管理策略必须优先考虑儿童的骨健康.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
398
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
398
COPD: Management Using Bronchodilators and Corticosteroids
319
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
319
Asthma: Pathogenesis and Management
606
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
606
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471


